MTOR and esophageal squamous cell carcinoma: In esophageal squamous cell carcinoma (ESCC), CLIC1’s elevated expression aligns with clinical TNM classifications, and its inhibition may promote the mTOR signaling pathway, impacting cell proliferation (Geng et al.).